FindTrial
Sign In

Research of application methodology about QiJingShengBai Formula treat leukopenia caused by chemotherapy based on real world registration study

Research of application methodology about QiJingShengBai Formula treat leukopenia caused by chemotherapy based on real world registration study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OON-17011909
Enrollment
Unknown
Registered
2017-07-08
Start date
2017-07-21
Completion date
Unknown
Last updated
2017-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leukocytopia after chemotherapy

Interventions

Two cohorts:QiJingShengBai Formula versus without QiJingShengBai Formula

Sponsors

second affiliated hospital of TianJin university of TCM
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged greater than or equal to 18 years; 2. Leukopenia caused by chemotherapy(WBC<3.5×10^9/L); 3. More than or equal to 5 days taking traditional Chinese medicine medicinal broth; 4. Signed informed consent form.

Exclusion criteria

Exclusion criteria: Treat leukopeni with Chinese patent drug

Design outcomes

Primary

MeasureTime frame
Leukocyte count;—

Secondary

MeasureTime frame
symptom improvement;—

Countries

China

Contacts

Public ContactYuhong Huang

second affiliated hospital of TianJin university of TCM

hyh101@126.com+86 022-60335308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026